"Leukemia, Mast-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of systemic mastocytosis (MASTOCYTOSIS, SYSTEMIC) characterized by the presence of large numbers of tissue MAST CELLS in the peripheral blood without skin lesions. It is a high-grade LEUKEMIA disease with bone marrow smear of >20% MAST CELLS, multi-organ failure and a short survival.
| Descriptor ID |
D007946
|
| MeSH Number(s) |
C04.557.337.440 C04.557.337.539.275.440 C04.557.450.565.465.750.500
|
| Concept/Terms |
Leukemia, Mast-Cell- Leukemia, Mast-Cell
- Leukemia, Mast Cell
- Leukemias, Mast-Cell
- Mast-Cell Leukemias
- Mast-Cell Leukemia
- Mast Cell Leukemia
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Mast-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Mast-Cell".
This graph shows the total number of publications written about "Leukemia, Mast-Cell" by people in this website by year, and whether "Leukemia, Mast-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Mast-Cell" by people in Profiles.
-
London CA, Acquaviva J, Smith DL, Sequeira M, Ogawa LS, Gardner HL, Bernabe LF, Bear MD, Bechtel SA, Proia DA. Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors. Clin Cancer Res. 2018 12 15; 24(24):6396-6407.